^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Convergent Genomics

    i
    Other names: Convergent Genomics
    Related tests:
    Evidence

    News

    1year
    New study shows UroAmp can detect bladder cancer not found by cystoscopy or urine cytology (PRNewswire)
    "UroAmp, the noninvasive genomic urine test developed by Convergent Genomics, can detect bladder cancer or predict its recurrence before clinical signs or symptoms appear, according to a newly published study in the journal Clinical Cancer Research...In a multi-center case-control study, researchers from leading academic centers and urology practices throughout the United States* compared UroAmp's diagnostic and prognostic performance for bladder cancer to standard-of-care procedures, like cystoscopy, cytology and pathology."
    Clinical data
    |
    UroAmp